The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer

被引:7
|
作者
Euhus, Caleb J. [1 ]
Ripley, Taylor R. [1 ]
Medina, Cristian G. [1 ]
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Thorac Surg, 1 Moursund St, Houston, TX 77030 USA
关键词
oligometastatic non-small cell lung cancer; metastatic non-small cell lung cancer; NSCLC history; lung cancer staging; surgery and NSCLC; local consolidative therapy (LCT); locally-aggressive therapy (LAT); LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; THERAPY; RADIOTHERAPY; CLASSIFICATION; MULTICENTER; PROGRESSION; METASTASIS; MANAGEMENT; RESECTION;
D O I
10.3390/cancers14102524
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patients for locally aggressive therapy, and researchers will be primed to design the next generation of studies that prioritize treatments in the management of this historically deadly disease. Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging criteria establishes this distinction. Oligometastatic NSCLC describes a patient subgroup with limited metastasis to one or a few organs. These patients seem to have a more indolent cancer than those with diffuse metastasis. For these select patients with oligometastatic disease, the use of palliative systemic therapy over local aggressive treatment may be a missed opportunity to improve survival. The clear definition of this subgroup and identification of the best treatment remains the current challenge in the management of the disease. Surgery was the early cornerstone in the treatment of limited disease; however, as modalities such as chemotherapy, stereotactic radiosurgery, and immunotherapy have matured, the role of excision is less clearly defined. There are sparse randomized controlled trials comparing the efficacy of different treatment modalities in patients with oligometastatic NSCLC. However, there is a growing body of retrospective research detailing the prognostic factors that characterize the role of surgery in the management of these patients. This article clarifies the context and definition of the term oligometastatic, as it applies to NSCLC, and reviews the current results in the use of surgery for its management.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Review of Treatment Options for Oligometastatic Non-Small Cell Lung Cancer
    Folkert, Michael R.
    Timmerman, Robert
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (03) : 186 - 193
  • [42] A novel paradigm in the treatment of oligometastatic non-small cell lung cancer
    Jabbour, S. K.
    Daroui, P.
    Gabel, M.
    Sovak, M.
    Cohler, A.
    Aisner, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S469 - S469
  • [43] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
    Suh, Yang-Gun
    Cho, Jaeho
    RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
  • [44] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [45] Local consolidative therapy for oligometastatic non-small cell lung cancer
    Samson, Pamela P.
    Spraker, Matthew B.
    Badiyan, Shahed N.
    Vlacich, Gregory
    Robinson, Clifford G.
    Chaudhuri, Aadel A.
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5649 - 5651
  • [46] Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer
    Till Plönes
    Thomas Osei-Agyemang
    Alexander Krohn
    Bernward Passlick
    Indian Journal of Surgery, 2015, 77 : 216 - 220
  • [47] Risk factors and management of oligometastatic non-small cell lung cancer
    Patel, Akshar N.
    Simone, Charles B., II
    Jabbour, Salma K.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (04) : 338 - 348
  • [48] Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer
    Kim, Chul
    Hoang, Chuong D.
    Kesarwala, Aparna H.
    Schrump, David S.
    Guha, Udayan
    Rajan, Arun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 179 - 193
  • [49] Surgery for oligometastatic disease in non-small-cell lung cancer
    Van Schil, Paul E.
    Hendriks, Jeroen M.
    Carp, Laurens
    Lauwers, Patrick R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (12) : 1931 - 1938
  • [50] The Role of Surgery for Elderly Patients of Non-Small Cell Lung Cancer
    Yoo, Byung Su
    Kang, Chang Hyun
    Kim, Young Tae
    Kim, Joo Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S412 - S413